Don M Bailey - Net Worth and Insider Trading

Don M Bailey Net Worth

The estimated net worth of Don M Bailey is at least $7 Million dollars as of 2024-04-24. Don M Bailey is the Director of Staar Surgical Co and owns about 145,139 shares of Staar Surgical Co (STAA) stock worth over $7 Million. Don M Bailey is the Director of Lineage Cell Therapeutics Inc and owns about 158,801 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $178,651. Don M Bailey is also the Director of Asterias Biotherapeutics Inc and owns about 88,235 shares of Asterias Biotherapeutics Inc (AST) stock worth over $83,382. Besides these, Don M Bailey also holds Mallinckrodt PLC (MNKKQ) , Comarco Inc (CMRO) . Details can be seen in Don M Bailey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Don M Bailey has not made any transactions after 2024-02-08 and currently still holds the listed stock(s).

Transaction Summary of Don M Bailey

To

Don M Bailey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Don M Bailey owns 7 companies in total, including Lineage Cell Therapeutics Inc () , Asterias Biotherapeutics Inc () , and OncoCyte Corp () among others .

Click here to see the complete history of Don M Bailey’s form 4 insider trades.

Insider Ownership Summary of Don M Bailey

Ticker Comapny Transaction Date Type of Owner
Lineage Cell Therapeutics Inc 2024-02-08 director
Asterias Biotherapeutics Inc 2018-06-21 director
OncoCyte Corp 2016-08-29 director
Mallinckrodt PLC 2015-05-13 director
Staar Surgical Co 2011-08-05 director
Comarco Inc 2007-06-11 director
Mallinckrodt PLC 2014-08-14 director

Don M Bailey Latest Holdings Summary

Don M Bailey currently owns a total of 5 stocks. Among these stocks, Don M Bailey owns 145,139 shares of Staar Surgical Co (STAA) as of August 5, 2011, with a value of $7 Million and a weighting of 96.33%. Don M Bailey owns 158,801 shares of Lineage Cell Therapeutics Inc (LCTX) as of February 8, 2024, with a value of $178,651 and a weighting of 2.46%. Don M Bailey also owns 88,235 shares of Asterias Biotherapeutics Inc (AST) as of May 13, 2016, with a value of $83,382 and a weighting of 1.15%. The other 2 stocks Mallinckrodt PLC (MNKKQ) , Comarco Inc (CMRO) have a combined weighting of 0.05% among all his current holdings.

Latest Holdings of Don M Bailey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
STAA Staar Surgical Co 2011-08-05 145,139 48.14 6,986,991
LCTX Lineage Cell Therapeutics Inc 2024-02-08 158,801 1.13 178,651
AST Asterias Biotherapeutics Inc 2016-05-13 88,235 0.95 83,382
MNKKQ Mallinckrodt PLC 2015-05-13 139,607 0.02 2,792
CMRO Comarco Inc 2005-01-18 57,386 0.02 1,176

Holding Weightings of Don M Bailey


Don M Bailey Form 4 Trading Tracker

According to the SEC Form 4 filings, Don M Bailey has made a total of 0 transactions in Staar Surgical Co (STAA) over the past 5 years. The most-recent trade in Staar Surgical Co is the acquisition of 50,802 shares on August 5, 2011, which cost Don M Bailey around $280,935.

According to the SEC Form 4 filings, Don M Bailey has made a total of 1 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 96,155 shares on February 8, 2024, which cost Don M Bailey around $100,001.

According to the SEC Form 4 filings, Don M Bailey has made a total of 0 transactions in Asterias Biotherapeutics Inc (AST) over the past 5 years. The most-recent trade in Asterias Biotherapeutics Inc is the acquisition of 88,235 shares on May 13, 2016, which cost Don M Bailey around $299,117.

More details on Don M Bailey's insider transactions can be found in the Insider Trading History of Don M Bailey table.

Insider Trading History of Don M Bailey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Don M Bailey Trading Performance

GuruFocus tracks the stock performance after each of Don M Bailey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Don M Bailey is 57.08%. GuruFocus also compares Don M Bailey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Don M Bailey within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Don M Bailey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Don M Bailey

Average Return

-32.8%

Average return per transaction

Outperforming Transactions

40%

2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.56 57.08 3.52 -32.8 21.73 23.43
Relative Return to S&P 500(%) 14.6 59.45 22.8 -20.16 21.27 20.55

Don M Bailey Ownership Network

Ownership Network List of Don M Bailey

No Data

Ownership Network Relation of Don M Bailey


Don M Bailey Owned Company Details

What does Lineage Cell Therapeutics Inc do?

Who are the key executives at Lineage Cell Therapeutics Inc?

Don M Bailey is the director of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include 10 percent owner Broadwood Partners Lp , Chief Financial Officer Jill Ann Howe , and director & President and CEO Brian M Culley .

Lineage Cell Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Don M Bailey made 1 insider transaction in Lineage Cell Therapeutics Inc () with a net purchase of 96,155. Other recent insider transactions involving Lineage Cell Therapeutics Inc () include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 10,000 shares made by Anula Jayasuriya ,

In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc () in total and bought 6,826,925 shares, with a net purchase of 6,826,925 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc () were sold and 6,836,925 shares were bought by its insiders, resulting in a net purchase of 6,836,925 shares.

Lineage Cell Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lineage Cell Therapeutics Inc Insider Transactions

No Available Data

Don M Bailey Mailing Address

Above is the net worth, insider trading, and ownership report for Don M Bailey. You might contact Don M Bailey via mailing address: 1300 N. Kellogg Drive, Suite D, Anaheim Ca 92607.

Discussions on Don M Bailey

No discussions yet.